advertisement
11.4 Prostaglandins (26)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins59491 The Effect of Long-term Antiglaucomatous Drug Administration on Central Corneal Thickness
Schrems WA; Schrems-Hoesl LM; Mardin CY; Horn FK; Juenemann AG; Kruse FE; Braun JM; Laemmer R
Journal of Glaucoma 2016; 25: 274-280
59348 Influence of latanoprost on retinal microcirculation in glaucoma
Kremmer S; Iliadou M; Anastassiou G; Schallenberg M; Vilser W; Steuhl KP; Selbach JM
Open Ophthalmology Journal 2014; 8: 60-66
59487 The diurnal and nocturnal effects of travoprost in normal-tension glaucoma
Seibold LK; Kahook MY
Clinical Ophthalmology 2014; 8: 2189-2193
59654 Effect on intraocular pressure of switching from latanoprost and travoprost monotherapy to timolol fixed combinations in patients with normal-tension glaucoma
Igarashi R; Togano T; Sakaue Y; Yoshino T; Ueda J; Fukuchi T
Journal of Ophthalmology 2014; 2014: 720385
59490 Meta-analysis of the Efficacy and Safety of Latanoprost Monotherapy in Patients With Angle-closure Glaucoma
Chen R; Yang K; Zheng Z; Ong ML; Wang NL; Zhan SY
Journal of Glaucoma 2016; 25: e134-e144
59577 Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
Dubiner HB; Hubatsch DA
BMC Ophthalmology 2014; 14: 151
59445 Efficacy and tolerability of mono-compound topical treatments for reduction of intraocular pressure in patients with primary open angle glaucoma or ocular hypertension: an overview of reviews
Daka Q; Trkulja V
Croatian Medical Journal 2014; 55: 468-480
59264 Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma
Mishra D; Sinha BP; Kumar MS
Korean Journal of Ophthalmology 2014; 28: 399-407
59452 Characterization of prostaglandin F2α receptors in human eyelids
Nesher R; Mimouni M; Elnaddaf H; Nemet A; Kidron D
European Journal of Ophthalmology 2014; 0: 0
59381 Latanoprost in the treatment of glaucoma
Alm A
Clinical Ophthalmology 2014; 8: 1967-1985
59101 Hirsutism following the use of bimatoprost eyedrops for glaucoma
Kaliaperumal S; Govindaraj I; Kopparapu PK; Ahuja S
Journal of pharmacology & pharmacotherapeutics 2014; 5: 208-210
59407 Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients
Gao LC; Wang D; Liu FQ; Huang ZY; Huang HG; Wang GH; Chen X; Shi QZ; Hong L; Wu LP; Tang J
European Journal of Clinical Pharmacology 2015; 71: 43-50
59050 Comparative Efficacy and Tolerability of Topical Prostaglandin Analogues for Primary Open-Angle Glaucoma and Ocular Hypertension
Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
Annals of Pharmacotherapy 2014; 48: 1585-1593
59146 Pharmacology of topical prostaglandin F2 α analogs and their place in the treatment of glaucoma in small animals
Maślanka T
Journal of veterinary pharmacology and therapeutics 2015; 38: 105-112
58835 The role of latanoprost in an inflammatory bowel disease flare
Paul S; Wand M; Emerick GT; Richter JM
Gastroenterology report 2014; 2: 232-234
58794 Meta-analysis of randomized controlled trials comparing latanoprost with other glaucoma medications in chronic angle-closure glaucoma
Li J; Lin X; Yu M
European Journal of Ophthalmology 2014; 25: 18-26
59421 Original and Generic Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: Are They Really the Same?
Golan S; Rosenfeld E; Shemesh G; Kurtz S
Clinical and Experimental Pharmacology and Physiology 2015; 42: 220-224
59151 Incidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution
Sakata R; Shirato S; Miyata K; Aihara M
Eye 2014; 28: 1446-1451
59188 Accidental Overdose of Travoprost
Goodwin D; Erickson DH
Optometry and Vision Science 2014; 91: e298-e300
58742 Switching efficacy on intraocular pressure from latanoprost to bimatoprost in eyes with open angle glaucoma: implication to the changes of central corneal thickness
Sawada A; Yamamoto T
Japanese Journal of Ophthalmology 2014; 58: 423-428
58516 Prospects for lentiviral vector mediated prostaglandin F synthase gene delivery in monkey eyes in vivo
Lee ES; Rasmussen CA; Filla MS; Slauson SR; Kolb AW; Peters DM; Kaufman PL; Gabelt BT; Brandt CR
Current Eye Research 2014; 39: 859-870
59426 Fixed combination of latanoprost and timolol vs the individual components for primary open angle glaucoma and ocular hypertension: a systematic review and meta-analysis
Xing Y; Jiang FG; Li T
International Journal of Ophthalmology 2014; 7: 879-890
59198 The Efficacy of a Latanoprost/Timolol Fixed Combination Versus Latanoprost and Timolol Gel-forming Solution Unfixed Combination on Daytime Intraocular Pressure
Ozyol E; Ozyol P
Journal of Glaucoma 2016; 25: 135-139
59231 Double-masked, Randomized, Dose-Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure
Bacharach J; Dubiner HB; Levy B; Kopczynski CC; Novack GD;
Ophthalmology 2015; 122: 302-307
59094 Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models
Mohammadi S; Jones L; Gorbet M
PLoS ONE 2014; 9: e106653
